Literature DB >> 23048195

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.

Vasim Farooq1, Yvonne Vergouwe, Lorenz Räber, Pascal Vranckx, Hector Garcia-Garcia, Roberto Diletti, Arie Pieter Kappetein, Marie Angèle Morel, Ton de Vries, Michael Swart, Marco Valgimigli, Keith D Dawkins, Stephan Windecker, Ewout W Steyerberg, Patrick W Serruys.   

Abstract

BACKGROUND: The SYNTAX score (SXscore), an anatomical-based scoring tool reflecting the complexity of coronary anatomy, has established itself as an important long-term prognostic factor in patients undergoing percutaneous coronary intervention (PCI). The incorporation of clinical factors may further augment the utility of the SXscore to longer-term risk stratify the individual patient for clinical outcomes. METHODS AND
RESULTS: Patient-level merged data from >6000 patients in seven contemporary coronary stent trials was used to develop a logistic regression model-the Logistic Clinical SXscore-to predict 1-year risk for all-cause death and major adverse cardiac events (MACE). A core model (composed of the SXscore, age, creatinine clearance, and left ventricular ejection fraction) and an extended model [incorporating the core model and six additional (best performing) clinical variables] were developed and validated in a cross-validation procedure. The core model demonstrated a substantial improvement in predictive ability for 1-year all-cause death compared with the SXscore in isolation [area under the receiver operator curve (AUC): core model: 0.753, SXscore: 0.660]. A minor incremental benefit of the extended model was shown (AUC: 0.791). Consequently the core model alone was retained in the final the Logistic Clinical SXscore model. Validation plots confirmed the model predictions to be well calibrated. For 1-year MACE, the addition of clinical variables did not improve the predictive ability of the SXscore, secondary to the SXscore being the predominant determinant of all-cause revascularization.
CONCLUSION: The Logistic Clinical SXscore substantially enhances the prediction of 1-year mortality after PCI compared with the SXscore, and allows for an accurate personalized assessment of patient risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23048195     DOI: 10.1093/eurheartj/ehs295

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

1.  Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI.

Authors:  Jan-Malte Sinning; Tobias Asdonk; Christoph Erlhöfer; Mariuca Vasa-Nicotera; Eberhard Grube; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2013-07-24       Impact factor: 5.460

2.  Association of epicardial fat thickness with TIMI risk score.

Authors:  S Balta; U Canpolat
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

3.  Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.

Authors:  William B Hillegass; Gregory S Bradford
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Doubling up on antiplatelet therapy after CABG: changing practice ASAP after DACAB?

Authors:  Daniel J F M Thuijs; Milan Milojevic; Stuart J Head
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions.

Authors:  David van Klaveren; Yvonne Vergouwe; Vasim Farooq; Patrick W Serruys; Ewout W Steyerberg
Journal:  J Clin Epidemiol       Date:  2015-02-27       Impact factor: 6.437

6.  Intervention: Logistic Clinical SYNTAX score.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

7.  SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.

Authors:  Christoph Sinning; Elvin Zengin; Christoph Waldeyer; Moritz Seiffert; Renate B Schnabel; Edith Lubos; Tanja Zeller; Christoph Bickel; Stefan Blankenberg; Peter M Clemmensen; Dirk Westermann
Journal:  Clin Res Cardiol       Date:  2016-06-30       Impact factor: 5.460

8.  [ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].

Authors:  H Nef; M Renker; C W Hamm
Journal:  Herz       Date:  2014-12       Impact factor: 1.443

9.  Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.

Authors:  Alexis Matteau; Robert W Yeh; Edoardo Camenzind; P Gabriel Steg; William Wijns; Joseph Mills; Anthony Gershlick; Mark de Belder; Gregory Ducrocq; Laura Mauri
Journal:  Am J Cardiol       Date:  2015-06-03       Impact factor: 2.778

10.  Impact of diabetes on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention.

Authors:  Zhen Ye; Qin Chen; Jiaxin Zhong; Long Chen; Lihua Chen; Mingfang Ye; Yuanming Yan; Lianglong Chen; Yukun Luo
Journal:  J Diabetes Investig       Date:  2022-03-29       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.